Clinical Trial Update: Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management

View source ↗

Summary

A completed pilot trial evaluating biomarker-based risk stratification to guide management in Barrett's Esophagus and potential progression to Esophageal Adenoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Esophageal Adenocarcinoma
• Esophageal Dysplasia
• Intestinal Metaplasia of Esophagus

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Barrett's Esophagus, Esophageal Adenocarcinoma | Status: COMPLETED